Notice of Half-Year Report
Faron Pharmaceuticals Oy (“Faron” or the “Company”) Faron Pharmaceuticals to Report Half-Year Financial Results on Thursday, August 26, 2021 Company announcement, July 28, 2021 at 7:00 am BST / 9:00 am EEST TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announces that it will report unaudited half-year financial results for the six months ended June 30, 2021